Serum Bile Acid Levels,lipid profile and alkaline phosphatase as a Predictor of Severity of Liver Fibrosis in Patients with chronic hepatitis C
Sameh Sabri Al-Mitwaly Al-Said;
Abstract
Liver fibrosis occurs in response to chronic liver injury
or disease, such as hepatitis C. Eighty percent (80%) of acutely
infected hepatitis C patients will become chronically infected
and approximately 16% will further progress to cirrhosis over
20 years, though studies have reported large variances
(Chopra, 2014).
Advanced fibrosis has been found to lead to a 10%
annual chance of progressing to cirrhosis, though it may not
progress in all patients, and studies have found the mean time
to progress to cirrhosis to be 30 years.5 Short-term liver related
morbidity is not generally expected in patients with F0 and F1
(Thein et al., 2008).
Metabolic profiles correlate with hepatitis C virus
(HCV) infection and are known to be predictors of virologic
responses in chronic hepatitis C patients on interferon-based
treatment. However, little is known about the differential
association of lipid profiles with hepatitis C viral load between
genotype 1 and 2 infections (Miyanari et al., 2007).
Serum bile acids (SBAs) are commonly elevated in
cholestatic liver diseases, but it is unclear if SBA levels are also
elevated in non-cholestatic chronic liver diseases and whether
levels correlate with disease severity (Miyanari et al., 2007).
Summary and Conclusion
- 102 -
Elevation of ALP is observed in patients who have some
form of extra hepatic and intra hepatic bile duct obstruction.
Any mechanism that impaired excretion of ALP in bile will
result in regurgitation of enzyme into circulation via the hepatic
sinusoid. The increased ALP present in the patients with
disease closely resembles the ALP that can be extracted from
liver (Nyblom. et al., 2004).
The increased cholestatis stimulates the synthesis of
ALP by the bile ductules cell providing more ALP which
ultimately enters the bloods, the amphillic nature of bile salts
facilitates the release of ALP from its membranes bound site
and entry into blood (Nyblom. et al., 2004).
A proportional relationship is found between serum
lipid profiles and hepatitis C viral load in patients with
genotype 2 infection; however, whether manipulation of lipid
profi les would improve the response to current anti-HCV
therapy is to be determined in further studies (Hsu et al., 2009).
This study was carried out in hepatitis treatment unit,
Al-Ahrar hospital, Zagazig from May 2015 to May 2016.
We aimed to assess the role of level of bile acid, lipid
profile and alkaline phosphatase as a non-invassive method
in relation to liver fibrosis in patient with hepatitis HCV.
Summary and Conclusion
- 103 -
The study results showed that there was statistically
significant increase (p<0.05) of ALP level in smoker patients
compared to nonsmoker patients. Statistical results revealed
that there was high statistically significant increase
(p<0.001) of bile acid level in patients aged 45 years old
and in patients with hepatic or splenic enlargement compared
to other patients.
There was high st
or disease, such as hepatitis C. Eighty percent (80%) of acutely
infected hepatitis C patients will become chronically infected
and approximately 16% will further progress to cirrhosis over
20 years, though studies have reported large variances
(Chopra, 2014).
Advanced fibrosis has been found to lead to a 10%
annual chance of progressing to cirrhosis, though it may not
progress in all patients, and studies have found the mean time
to progress to cirrhosis to be 30 years.5 Short-term liver related
morbidity is not generally expected in patients with F0 and F1
(Thein et al., 2008).
Metabolic profiles correlate with hepatitis C virus
(HCV) infection and are known to be predictors of virologic
responses in chronic hepatitis C patients on interferon-based
treatment. However, little is known about the differential
association of lipid profiles with hepatitis C viral load between
genotype 1 and 2 infections (Miyanari et al., 2007).
Serum bile acids (SBAs) are commonly elevated in
cholestatic liver diseases, but it is unclear if SBA levels are also
elevated in non-cholestatic chronic liver diseases and whether
levels correlate with disease severity (Miyanari et al., 2007).
Summary and Conclusion
- 102 -
Elevation of ALP is observed in patients who have some
form of extra hepatic and intra hepatic bile duct obstruction.
Any mechanism that impaired excretion of ALP in bile will
result in regurgitation of enzyme into circulation via the hepatic
sinusoid. The increased ALP present in the patients with
disease closely resembles the ALP that can be extracted from
liver (Nyblom. et al., 2004).
The increased cholestatis stimulates the synthesis of
ALP by the bile ductules cell providing more ALP which
ultimately enters the bloods, the amphillic nature of bile salts
facilitates the release of ALP from its membranes bound site
and entry into blood (Nyblom. et al., 2004).
A proportional relationship is found between serum
lipid profiles and hepatitis C viral load in patients with
genotype 2 infection; however, whether manipulation of lipid
profi les would improve the response to current anti-HCV
therapy is to be determined in further studies (Hsu et al., 2009).
This study was carried out in hepatitis treatment unit,
Al-Ahrar hospital, Zagazig from May 2015 to May 2016.
We aimed to assess the role of level of bile acid, lipid
profile and alkaline phosphatase as a non-invassive method
in relation to liver fibrosis in patient with hepatitis HCV.
Summary and Conclusion
- 103 -
The study results showed that there was statistically
significant increase (p<0.05) of ALP level in smoker patients
compared to nonsmoker patients. Statistical results revealed
that there was high statistically significant increase
(p<0.001) of bile acid level in patients aged 45 years old
and in patients with hepatic or splenic enlargement compared
to other patients.
There was high st
Other data
Title | Serum Bile Acid Levels,lipid profile and alkaline phosphatase as a Predictor of Severity of Liver Fibrosis in Patients with chronic hepatitis C | Other Titles | مستوى حامض الصفراء، والدهون بالدم والفوسفاتاز القلويه كمؤشر لدرجه التليف الكبدى للمرضى الذين يعانون من التهاب كبدى فيروسى سى | Authors | Sameh Sabri Al-Mitwaly Al-Said | Issue Date | 2017 |
Attached Files
File | Size | Format | |
---|---|---|---|
J 1017.pdf | 136.69 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.